World's most portable molecular diagnostics system unveiled at AACC

GeneXpert Omni to further decentralize critical TB, virology and Ebola tests.

Read More →

Is domestic finance the future of TB financing?

While international financing for TB has grown since 2002, it remains a paltry sum compared with the vast amounts of money channeled to other infectious diseases, such as HIV and AIDS.

Read More →

Tumor-fighting drugs take on tuberculosis

By bridging the gaps that divide cancer, immunology, and microbiology, researchers may yet find creative and affordable ways to address the growing problem of drug-resistant tuberculosis.

Read More →

Successes in HIV overshadow failures in TB

In the new world of intensifying budget competition -- flat global health budgets, a widening post-2015 agenda, growing demand to address other non-communicable diseases -- TB is very vulnerable to becoming even more lost.

Read More →

Joint call regarding health crisis in Donbas, East Ukraine

Stocks of medicines for drug-resistant tuberculosis are insufficient, and further shortages – leading to more tuberculosis and more drug resistance – are expected.

Read More →

Global Plan to Stop TB 2016-2020 Regional Consultation in Europe: Why we need to change now if we want to End TB

The European region has special challenges to face: high MDR and XDR-TB rates, lengthy hospital stays, and the need for changes in health, human rights policies including decriminalization, real civil society and community engagement.

Read More →

Leaked: draft 2015 report on Indian Revised National TB Control Programme from Joint Monitoring Mission

Central TB Division (CTD) organised the Joint Monitoring Mission (JMM) in April 2015 along with the World Health Organisation country office to review the functioning of the Revised National TB Control Programme (RNTCP) of India.

Read More →

TB community reiterates request to Johns Hopkins to review sutezolid licensing agreement with Sequella

The TB CAB and TAG restate their request to Johns Hopkins University to allow representatives of TB-affected communities to comment on the terms of any agreement with Sequella before it is finalized.

Read More →

MSF report: HIV/TB counselling: who is doing the job?

New MSF report surveying lay counsellor policies across eight countries highlights major weaknesses for adherence support.

Read More →

New figures show alarming trends in TB financing

Despite the critical need for increased TB resources, donor funding for TB decreased by nearly 10% in 2014.

Read More →

Page 1 of 59 · Total posts: 10

1 2 Last→